FOXO3 rs2153960: Longevity and Metabolic Regulation
The rs2153960 variant is a non-coding single nucleotide polymorphism located within the FOXO3 gene on chromosome 6. Research associates this variant with the regulation of insulin and insulin-like growth factor 1 (IGF-1) signaling pathways, as well as exceptional human longevity. As part of an extensive linkage disequilibrium block, it serves as a prominent marker in population-based studies exploring human healthspan and cellular stress resistance.
What each genotype means
Baseline longevity association
This genotype represents the major allele configuration for this FOXO3 variant. Research suggests this configuration is associated with standard insulin/IGF-1 pathway activity levels in the context of human aging studies.
This is the most common genotype in European populations, carried by approximately 38% of individuals.
Intermediate longevity association
Carrying one copy of the G allele may provide an intermediate influence on FOXO3 expression and insulin/IGF-1 signaling compared to the homozygous states. Statistical associations with healthy aging and longevity are often observed in a dose-dependent manner with the G allele.
This heterozygous genotype is found in a significant portion of the population, reflecting the common nature of the G allele in many ancestries.
Enhanced longevity association
This genotype is frequently studied for its association with increased longevity and healthy aging phenotypes, including improved insulin sensitivity. Research indicates this variant may modulate the insulin/IGF-1 signaling pathway, potentially contributing to resilience against age-related stressors.
The G allele has a minor allele frequency of approximately 0.38 in European and 0.25 in Asian ancestries, making this homozygous genotype less common than the others.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs2153960 is an intronic variant mapped to chromosome 6q21 within the forkhead box O3 (FOXO3) gene. Positioned within non-coding sequence, this variant does not alter the underlying amino acid sequence of the FoxO3 protein directly. Instead, research indicates that non-coding polymorphisms across this genomic segment frequently operate as regulatory elements, influencing transcriptional efficiency, alternative splicing, or chromatin conformation. A crucial genomic feature of the FOXO3 locus is its pronounced linkage disequilibrium, meaning clusters of nearby genetic variants are consistently inherited together as haplotypes. Because rs2153960 exists in high linkage disequilibrium with other well-documented longevity alleles—such as rs13217795 and rs2802288—it often functions as a reliable proxy marker in genetic mapping and population studies evaluating healthy aging.
Biological Role of the FOXO3 Transcription Factor
FOXO3 encodes a key member of the forkhead transcription factor family that directs cellular adaptation to environmental and metabolic stressors. Operating downstream of the evolutionary conserved insulin and insulin-like growth factor 1 (IGF-1) signaling cascade, FoxO3 translocates to the cell nucleus during conditions of low nutrient availability or elevated oxidative stress. Once inside the nucleus, it orchestrates the transcription of programs governing DNA repair, autophagy, antioxidant defense, cell cycle arrest, and apoptosis. Downregulation of the insulin/IGF-1 pathway permits increased FoxO3 transcriptional activity, enhancing proteostasis and stem cell preservation. Animal models have long established that enhanced FoxO activity extends overall lifespan, while human studies confirm that genetic variation modulating FOXO3 expression influences metabolic homeostasis, inflammatory responses, and vulnerability to cardiovascular or age-related degeneration.
Longevity and Metabolic Evidence Across Populations
Genetic association studies have repeatedly evaluated FOXO3 variants in centenarians and long-lived cohorts across diverse ancestries, including Japanese-American, European, and East Asian populations. In multiple cohorts, specific alleles at rs2153960 and its proxy variants correlate with reduced circulating IGF-1 concentrations, improved insulin sensitivity, and enriched representation among individuals reaching extreme advanced age. However, the observed statistical strength of rs2153960 varies substantially across cohorts. While initial investigations identified robust associations in specific centenarian populations, other cohorts—such as the Dutch Leiden 85-plus study—observed non-significant results for this specific single-point marker, likely due to sample size constraints, survivor bias, or distinct underlying linkage architecture. Consequently, evidence supporting rs2153960 is classified as moderate, reflecting strong biological plausibility but population-dependent statistical replication.
Translating Population Genetics into Practical Context
Carrying a specific genotype at rs2153960 provides insight into statistical likelihoods observed in broad research cohorts, but it cannot determine or predict an individual's personal lifespan. Human longevity and healthspan are complex, polygenic traits governed by hundreds of minor genetic variants acting in concert with lifestyle, diet, socio-economic factors, and environmental exposures. An individual possessing longevity-associated alleles cannot assume immunity from chronic disease, nor does lacking them imply a shortened life expectancy. Furthermore, rs2153960 does not carry clinical diagnostic validity, and testing results should never be used to alter medical treatments or prescription drugs. Consumers should treat this data as educational context highlighting how cellular defense pathways interact with health, prioritizing established modifiable habits like regular exercise, balanced nutrition, and routine medical care.
How common is this variant?
The minor G allele has an estimated frequency of approximately 0.38 in populations of European ancestry and 0.25 in Asian ancestries according to global reference datasets like 1000 Genomes and gnomAD.
Frequently asked questions
Does having the FOXO3 rs2153960 longevity allele guarantee I will live to 100?
No, having a longevity-associated genotype does not guarantee an extended lifespan or centenarian status. Longevity is a highly complex trait influenced by hundreds of genetic factors alongside lifestyle choices, nutrition, environmental conditions, and access to medical care. The variant simply reflects a modest statistical association observed across population studies.
What is the biological function of the FOXO3 gene?
The FOXO3 gene provides instructions for producing a transcription factor protein that helps cells respond to oxidative stress, repair damaged DNA, clear cellular waste, and manage metabolism. It acts as an important molecular switch within the insulin and IGF-1 signaling networks to preserve cellular integrity.
Is rs2153960 a functional mutation or a genetic marker?
rs2153960 is located within an intron of FOXO3 and does not alter the protein's coding sequence. Current research suggests it acts as a regulatory variant or serves as a proxy marker that is inherited in tandem with other functional mutations in the same chromosomal region.
Can I use my rs2153960 genotype to guide my diet or medical treatments?
No, rs2153960 is not approved or intended for clinical diagnosis, personalized drug dosing, or dietary prescription. Any decisions regarding medication, supplements, or significant medical therapies should always be discussed directly with a qualified healthcare professional.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2153960?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FOXO3
Well-characterized non-headline FOXO3 variant associated with healthy aging, lower cardiovascular mortality, and survival beyond age 90.
Non-coding FOXO3 variant identified in longitudinal aging studies as conferring an advantage for survival from midlife into advanced old age.
Common upstream intronic regulatory variant in FOXO3 correlated with human longevity and enhanced resilience against metabolic disease.
Functional non-coding variant in the key longevity regulator FOXO3 contributing to extended survival and healthspan.
An intronic variant in the FOXO3 gene consistently associated with human longevity and survival to extreme old age across multiple ethnic cohorts.
Intronic variant in FOXO3 significantly associated with exceptional longevity and survival to advanced old age, showing allele-dependent enhancer activity.